USP Seeks Experts for 2015-2020 Council of Experts - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

USP Seeks Experts for 2015-2020 Council of Experts

The U.S. Pharmacopeial Convention (USP) has announced its call for candidates for the 2015–2020 Council of Experts, USP’s scientific decision-making body.

USP’s Council of Experts is responsible for developing and revising standards that are included in USP’s seven compendia: The United States Pharmacopeia and the National Formulary; Medicines Compendium; USP on Compounding; Herbal Medicines Compendium; Dietary Supplements Compendium; and Food Chemicals Codex.

Currently more than 30% of the Council’s members comprise experts from outside of the US. The 2015–2020 Council of Experts includes 26 Expert Committees, six of which will meet outside of the US. All Expert Committees are supported by USP’s international site and Rockville, Maryland headquarters staff. The 2015–2020 Council of Experts will benefit from USP’s network of laboratories, which includes over 170,000 square feet of laboratory resources and a global staff located in the US, India, China, and Brazil.

The Council of Experts is elected every five years at the meeting of the USP Convention, with the next meeting to take place in April 2015. New experts will begin their five-year tenure on July 1, 2015. Members of the Council of Experts serve as chairs of USP’s Expert Committees, each of which addresses a specific standards-setting area within USP. Theseareas include chemical medicines, biologic medicines, excipients, compounded preparations, dietary supplements, and food ingredients. USP is also seeking candidates to serve as members of Expert Committees.

Candidates may nominate themselves or a colleague at

Source: USP


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here